advertisement

WGA Rescources

Eye and vision (London, England) 10

Showing records 1 to 10 | Display all abstracts in Eye and vision (London, England)

95965 Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results
Salimi A
Eye and vision (London, England) 2021; 8: 43
96403 Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
Vastardis I
Eye and vision (London, England) 2021; 8: 33
95965 Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results
Salimi A
Eye and vision (London, England) 2021; 8: 43
96403 Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
Vastardis I
Eye and vision (London, England) 2021; 8: 33
95965 Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results
Salimi A
Eye and vision (London, England) 2021; 8: 43
96403 Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
Fili S
Eye and vision (London, England) 2021; 8: 33
95965 Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results
Watt H
Eye and vision (London, England) 2021; 8: 43
96403 Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
Perdikakis G; Perdikakis G
Eye and vision (London, England) 2021; 8: 33
95965 Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results
Harasymowycz P
Eye and vision (London, England) 2021; 8: 43
96403 Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
Kontopoulou K; Balidis M; Gatzioufas Z; Kohlhaas M
Eye and vision (London, England) 2021; 8: 33

Issue 22-3

Change Issue


advertisement

Oculus